Intensive Care Decision-making, Survival and Dying Well
The goal of this study is to investigate how the experiences of intensive care patients and their end-of-life wishes affect their willingness to accept intensive care treatment at different chances of survival. The main questions it aims to answer are: * What can ICU survivors' experiences of ICU treatment tell us abou
| Condition(s) | Critical Illness |
|---|---|
| Status | Recruiting |
| Study type | Observational |
| Summary | The goal of this study is to investigate how the experiences of intensive care patients and their end-of-life wishes affect their willingness to accept intensive care treatment at different chances of survival. The main questions it aims to answer are: * What can ICU survivors' experiences of ICU treatment tell us about what it would be like to die whilst receiving ICU treatment? * How do ICU survivors' reflections about what it might be like to die on ICU relate to their own preferences for their end-of-life care? * What chance of survival would make ICU survivors willing to go through ICU treatment again, in light of the fact that the alternative chance is dying whilst experiencing ICU treatment? * How does the possibility of reduction in health-related quality of life and functional dec |
| Who can participate | Inclusion Criteria: * The principle inclusion criteria are being 18 years or older and having previously been a patient on an intensive care/critical care unit in the past. * Being willing to talk about experiences of intensive care treatment, end-of-life wishes, and the context (chances of survival/functional decline) which would make intensive care treatments acceptable and being willing to either meet in person or have access to a computer, tablet or mobile phone with video and a stable internet connection (for a Zoom conversation) are also inclusion criteria. Exclusion Criteria: * The exclusion criteria are being under the age of 18, having had a planned admission to an intensive care/critical care unit (e.g. after an elective operation), being unable to consent to participate in the r |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | University of Manchester |
| Locations | Manchester, United Kingdom |
| Start date | 2023-10-02 |
| NCT ID | NCT06027684 |
| Official listing | https://clinicaltrials.gov/study/NCT06027684 |